HYRIMOZ 40 mg, solution for injection in a pre-filled pen (0.8 ml) 2 pens of 0.8 ml
Active ingredients: Adalimumab
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection2 pens of 0.8 mlsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- HYRIMOZ 40 mg, solution injectable en stylo prérempli (0,8 mL)
- Pharmaceutical form
- solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 2 stylos préremplis en verre de 0,8 mL
- Marketing authorisation holder
- SANDOZ (AUTRICHE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 2 Feb 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66112231CIP73015509CIP133400930155097Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ADALIMUMABsolution | 40 mg · un stylo prérempli unidose de 0,8 mL de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.